BRCA1 and breast cancer: Moreover, another in-depth TCGA analysis also pointed to the coexistence of anti-tumoral immune transcripts downregulation, such as IFN-γ related genes, with the upregulation of immunosuppressive markers related to myeloid tolerogenic cells activity in BRCA1 mutated breast cancers (41).